Selected Project Experience

• Enhancing Oncology Model (EOM), Center for Medicare & Medicaid Innovation (CMMI) (2024 to Present)—Task Lead, Drug Lists. Leads the development and public release of periodic oncology drug lists—including novel therapies, initiating therapies, and bispecific antibodies/CAR-T lists—for CMS’s Enhancing Oncology Model, an alternative payment model aimed at improving cancer care quality and outcomes while reducing costs. These drug lists define inclusion/exclusion criteria for patient episodes and reflect policy decisions. Oversaw end-to-end execution including historical policy review, coordination with subcontractors and pharmacy consultants, and preparation of 508-compliant deliverables for CMS approval. Spearheaded process optimization efforts by consolidating policy documentation (emails, SOPs, decision logs) and streamlining workflows with analysts and interns to enhance accuracy, efficiency, and knowledge continuity.

• Post-Acute Care (PAC) Quality Reporting Program (QRP), Centers for Medicare & Medicaid Services (CMS) (2024 to Present)—Analyst. Serve as Analyst and Function Measures Lead on CMS’s PAC Quality Reporting Program (QRP), which tracks and publicly reports the quality of care provided in post-acute care settings (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-term Care Hospitals) to promote transparency and improve patient outcomes. Led development of the inaugural measure monitoring workbook/dashboard after RTI assumed the contract, laying the groundwork to establish a scalable, low-maintenance framework to support the recurring deliverable. Additionally, supports Consensus-Based Entity packet submissions for quality measure endorsement by the Partnership for Quality Measurement (PQM). Played a key role in the successful endorsement of a cross-setting functional outcomes measure by PQM.

• Independent Evaluation of the New York Tobacco Control Program (NY TCP), New York State Department of Health (2023 to Present)—Analyst. Supports the independent evaluation of NY TCP, a comprehensive, evidence-based program aimed at reducing tobacco use and exposure across New York State. Contributes to data processing, statistical analysis, and development of deliverables using large-scale population survey datasets such as National Substance Use and Mental Health Services Survey (N-SUMHSS) and Uniform Data System (UDS). Supports ongoing surveillance and evaluation efforts to monitor cessation and prevention indicators. Ensures timely, accurate reporting to inform program strategy, implementation, and stakeholder engagement.

• Domestic and International Tobacco Control Policy Evaluation Support Services, U.S. Food and Drug Administration (FDA) (2023 to 2024)—Analyst. Conducted analyses to support the evaluation of domestic and international tobacco control policies for FDA’s Center for Tobacco Products. This work helped inform regulatory decisions and enforcement strategies aimed at reducing tobacco-related harm. Responsibilities included population survey data analysis, interpretation of findings, and preparation of summary reports.

• Look AHEAD (Action for Health in Diabetes) Clinical Trial Sex Hormone Study (2022 to 2023)—Biostatistician. Data management and analysis of the longitudinal clinical trial data to understand the impact of Intensive Lifestyle Intervention (ILI) in type 2 diabetes participants and the differences seen between postmenopausal women and men. Coordinated and collaborated with research team members including the laboratories and presented the initial results at American Heart Association’s Epidemiology conference, AHA-Epi 2023.

• Evaluation of Florida MIECHV program (2019 to 2021)—Project Coordinator and Analyst. Conducted quantitative data analysis (descriptive and regression models) using SAS 9.4 to understand infant sleep practices among MIECHV program participants. Evaluated fathers’ engagement in MIECHV programs—conducted focus groups, developed thematic areas, analyzed the data using MAXQDA qualitative software and developed the evaluation report. Disseminated results of the evaluation through Health Resources and Services Administration (HRSA) reports, manuscripts, and conference presentations. Conducted evaluation of low response rates on Florida PRAMS (Pregnancy Risk Assessment and Monitoring System) survey; reviewed literature, developed focus group guides, conducted focus groups, and developed thematic areas to analyze the transcripts. Assisted in identifying high-risk counties in need of home visiting services for the 2020 MIECHV Needs Assessment. Developed maps for the indicators and domains at the county and subcounty levels.

• Evaluation of Out-of-Pocket Expenditure Associated with Deliveries (2020)—Graduate Student. Analyzed Demographic Health Survey (DHS), India, as part of Integrated Learning Experience (ILE) during MPH work. Requested data from DHS with a proposal, and cleaned and analyzed the data using multinomial regression on SAS 9.4. Submitted report for ILE credit.

• Unmet Need for Substance Use Treatment Centers in Florida (2019)—Graduate Research Assistant/Analyst. Analyzed National Survey on Drug Use and Health (NSDUH) using negative binomial distribution model and ArcGIS to demonstrate the spatial inaccessibility to substance abuse treatment centers in Florida. This project was conducted as part of coursework (for Public Health GIS).

• Unmet Needs for Healthcare Among Children Born Preterm or with a Low Birthweight (2019)— Graduate Student. Analyzed National Survey of Children’s Health (NSCH) as part of coursework for Secondary Data Analysis in Maternal and Child Health.